$100M$250M
$1B$10B
$1M$10M
$50M$100M
$10M$25M
$250M$500M
$250M$500M
$500M$1B
$50M$100M
$100M$250MSpliceBio uses 8 technology products and services including WordPress, oEmbed, Underscore.js, and more. Explore SpliceBio's tech stack below.
| SpliceBio Email Formats | Percentage |
| First.Last@splice.bio | 46% |
| First.Middle@splice.bio | 4% |
| First.Last@splice.bio | 46% |
| First.Middle@splice.bio | 4% |
Biotechnology ResearchCatalonia, Spain51-200 Employees
SpliceBio is a biotechnology company exploiting Protein Splicing to develop the next generation of gene therapies. Our proprietary platform is based on technology developed in the Muir Lab at Princeton University after more than 20 years of pioneering intein and protein engineering research by our co-founders. The company is backed by UCB Ventures, Ysios Capital, NEA, Gilde Healthcare, Novartis Venture Fund and Asabys Partners.
Company Overview
Funding & FinancialsSpliceBio has raised a total of $135M of funding over 4 rounds. Their latest funding round was raised on Jun 11, 2025 in the amount of $135M.
SpliceBio's revenue is estimated to be in the range of $1M$10M
Funding & FinancialsSpliceBio has raised a total of $135M of funding over 4 rounds. Their latest funding round was raised on Jun 11, 2025 in the amount of $135M.
SpliceBio's revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com